European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 710-714 , September 2006

Introduction of sentinel node biopsy and stage migration of breast cancer

  • M. van der Heiden-van der Loo

      Affiliations

    • Comprehensive Cancer Centre Middle Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 30 233 8060; fax: +31 30 233 8079.
    • ,
  • P.D. Bezemer

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    • ,
  • A. Hennipman

      Affiliations

    • Department of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • S. Siesling

      Affiliations

    • Netherlands Cancer Registry, Utrecht, The Netherlands
    • ,
  • P.J. van Diest

      Affiliations

    • Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • V. Bongers

      Affiliations

    • Department of Nuclear Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands
    • ,
  • P.H.M. Peeters

      Affiliations

    • Julius Center Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands

,Accepted 5 April 2006.

References 

  1. Bourez RL, Rutgers EJ, van de Velde CJ. Will we need lymph node dissection at all in the future?. Clin Breast Cancer. 2002;3:315–322
  2. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275–283
  3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;391–401
  4. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;335–340
  5. Rahusen FD, Meijer S, van Diest PJ. Re: Chu et al “Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?”. Ann Surg. 2000;231:615–616
  6. Sandrucci S, Casalegno PS, Percivale P, Mistrangelo M, Bombardieri E, Bertoglio S. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori. 1999;85:425–434
  7. Tanis PJ, Nieweg OE, Valdes Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res. 2001;3:109–112
  8. Nieweg OE, Jansen L, Valdes Olmos RA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med. 1999;26:S11–S16
  9. Roumen RM, Pijpers HJ, Thunnissen FB, Ruers TJ. Summary of the guideline ‘Sentinel node biopsy in breast cancer.’ Dutch Work Group ‘Sentinel Node Biopsy for Breast Cancer’. Ned Tijdschr Geneeskd. 2000;144:1864–1867
  10. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394–399
  11. Tjan-Heijnen VC, Buit P, Widt-Evert LM, Ruers TJ, Beex LV. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat. 2001;70:81–88
  12. Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node. Eur J Surg Oncol. 2003;29:216–220
  13. Nationaal Borstkanker Overleg Nederland (NABON) . Richtlijn Behandeling van het mammacarcinoom. Available from: www.oncoline.nl2005;
  14. International Union Against Cancer (UICC) . TNM Classification of Malignant Tumours. New York: Wiley-Liss, Inc.; 1997;
  15. International Union Against Cancer (UICC) . TNM Classification of Malignant Tumours. Geneva: International Union Against Cancer (UICC); 1987;
  16. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol. 1998;24:316–319
  17. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003;39:1654–1667
  18. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J. 2004;10:101–105
  19. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE ALMANAC Trialists Group. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer. 2004;40:1731–1737
  20. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg. 2003;138:52–56
  21. Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001;136:688–692
  22. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg. 2004;240:462–468

☆ Sources of support: None.

PII: S0748-7983(06)00165-X

doi: 10.1016/j.ejso.2006.04.001

European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 710-714 , September 2006

Article Tools